| Literature DB >> 3262631 |
N D Francis1, D M Clark, A W Boylston.
Abstract
The use of a new monoclonal antibody, BF1, which reacts in routinely fixed tissues, directed against the beta chain of the T cell antigen receptor was assessed to determine its reactivity in a variety of normal tissues as well as in a number of B and T cell tumours and other lymphoid disorders. It reacted with all five of the unequivocal T cell tumours tested. BF1 will have widespread use in the assessment of lymphoid tissues in patients with the acquired immune deficiency syndrome (AIDS) and the differential diagnosis of tumours.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3262631 PMCID: PMC1141625 DOI: 10.1136/jcp.41.8.900
Source DB: PubMed Journal: J Clin Pathol ISSN: 0021-9746 Impact factor: 3.411